Trending/surrogate endpoints
Surrogate Endpoints Poor Proxy for Survival in Cancer Drug Approval Process
ROCHESTER, Minn. — Surrogate endpoints used to support the majority of new cancer drugs approved in the U.S. often lack formal study, according to the authors…
No information found.
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community